Collections

SIOP Asia 2025

274 articles

SIOP Asia 2025 Congress has taken place on April 12-15, 2025 in Saudi Arabia.
This conference aimed to unite experts and practitioners in pediatric oncology, fostering collaboration and shared learning to enhance outcomes for children facing cancer. The goal was to create a vibrant space for discussion, innovation, and partnership, ultimately driving progress in this critical field.
SIOP, and especially SIOP Asia, plays a vital role in advancing pediatric oncology through its commitment to collaboration and knowledge exchange. The contributions of the SIOP Asia community are invaluable, impacting both regional practices and the global pediatric oncology landscape.

Pediatric Oncology Importance of psychosocial support in enhancing mental health and quality of life in pediatric cancer patients
Kamila Askarova • Malikakhon Shukurova
doi.org/10.69690/ODMJ-018-0425-2491
Pediatric Oncology Use of Cabozantinib in addition to chemotherapy as a viable second line treatment option in Relapsed Refractory Malignant Osteogenic Sarcomas
Dale Jude Montes • Maharshi Trivedi • Helie Raval • Himangi Tak • Chinmay Doctor • Harsha Panchal
doi.org/10.69690/ODMJ-018-0425-2488
Pediatric Oncology Pediatric Lymphoblastic Lymphoma: Clinical course, challenges and treatment strategies
Ruksana Sidhique • Nikita Jakhar • Sharan Shanubhogue • Jagdish Prasad Meena • Aditya Kumar Gupta
doi.org/10.69690/ODMJ-018-0425-2477
Pediatric Oncology Elevated Procalcitonin and Proadrenomedullin Levels at Diagnosis and During Febrile Neutropenia in Pediatric Acute Leukemia: A Prospective Study from a Tertiary Care Center
Ruksana Sidhique • Jagdish Prasad Meena • Harshita Makkar • Aditya Kumar Gupta • Ashutosh Halder • Rachna Seth
doi.org/10.69690/ODMJ-018-0425-2475
Pediatric Oncology Pediatric desmoid fibromatosis – Experience from a tertiary care cancer hospital
Dale Jude Montes • Maharshi Trivedi • Helie Raval • Chinmay Doctor • Harsha Panchal
doi.org/10.69690/ODMJ-018-0425-2471
Pediatric Oncology NCI Standard risk B-cell Acute Lymphoblastic Leukemia – Ten year outcome from India. Where are we heading towards?
Annapoorani Ramasamy • Venkateshwaran VS
doi.org/10.69690/ODMJ-018-0425-2468
Pediatric Oncology Profile of neuroblastoma – experience from a tertiary paediatric oncology centre from a developing country
Rishab Bhurat • Mohanaraj Ramachandran • Julius Scott • Ashwini Arul • Latha M. Sneha • Madhu S • Satish Srinivas • Rajeswaran Rangasami • Leena Dennis Joseph
doi.org/10.69690/ODMJ-018-0425-2457
Pediatric Oncology Belumosudil is effective in Pediatric Patients with chronic Graft-versus-Host disease after failed Ruxolitinib treatment
Yuanyuan Chen • Xiaojun Xu • Fenfen Jin
doi.org/10.69690/ODMJ-018-0425-2454
Pediatric Oncology B-cell precursor Acute Lymphoblastic Leukemia with high hyperdiploidy who have detectable residual disease at the end of induction can be salvaged by treatment escalation
Aniruddha Rathore • Chetan Dhamne • Nirmalya Roy Moulik • Shyam Srinivasan • Akanksha Chichra • Vikramraj Gokhale • Ruchika Gavanang • Shripad Banavali • Gaurav Narula
doi.org/10.69690/ODMJ-018-0425-2439
Pediatric Oncology Treatment outcomes and late effects in Retinoblastoma survivors: Importance of survivor clinics
Rachna Seth • Bhavna Chawla
doi.org/10.69690/ODMJ-018-0425-2426
Pediatric Oncology Bacterial infections and paediatric cancer: Change in trends of pathogens from an Indian Centre
Shubhashree Acharya • Debabrata Mohapatra • Sanghamitra Padhi • Susmita Kumari Sahu • Hemanta Kumar Singh • Debashish Mishra
doi.org/10.69690/ODMJ-018-0425-2438
Pediatric Oncology Novel therapies in pediatric cancer care: A retrospective study from Armenia
Elya Minasyan • Ruzanna Papyan • Irina Melnichenko • Saten Hovhannisyan • Lusine Hakobyan • Samvel Iskanyan • Mariam Minasyan • Hayk Grigoryan • Gevorg Tamamyan • Lilit Sargsyan
doi.org/10.69690/ODMJ-018-0425-2393